Ignite Creation Date:
2025-12-24 @ 2:46 PM
Ignite Modification Date:
2026-02-07 @ 6:58 AM
Study NCT ID:
NCT00022659
Status:
COMPLETED
Last Update Posted:
2019-07-24
First Post:
2001-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Sponsor:
National Cancer Institute (NCI)
Organization: